Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,470
datasets available to search
ShareScore release 0.9.0
Dataset results
2,470 results for “Acute Myeloid Leukemia”
Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission
ClinicalTrials.gov study NCT00093470. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Panobinostat in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00723203. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CLAG Gleevec in Relapsed or Refractory Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00955916. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pilot Study of Erlotinib for the Treatment of Patients With de Novo Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01174043. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Idarubicin + Cytarabine and Lenalidomide in Patients With Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00831766. IPD Sharing: Not stated. Countries: 1. Publications: 0.
PF-04449913 For Patients With Acute Myeloid Leukemia at High Risk of Relapse After Donor Stem Cell Transplant
ClinicalTrials.gov study NCT01841333. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Clofarabine in Older Patients With Acute Myeloid Leukemia (AML) for Whom Chemotherapy Is Not Suitable
ClinicalTrials.gov study NCT00924443. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Erlotinib Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01664897. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pinometostat and Azacitidine in Treating Patients With Relapsed, Refractory, or Newly Diagnosed Acute Myeloid Leukemia With 11q23 Rearrangement
ClinicalTrials.gov study NCT03701295. IPD Sharing: YES. Countries: 1. Publications: 0.
Trial of CPX-351 in Adult Patients With First Relapse Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00822094. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Guadecitabine With or Without Idarubicin or Cladribine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02096055. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of the Safety and Efficacy of Gemtuzumab Ozogamicin (GO) and Venetoclax in Patients With Relapsed or Refractory CD33+ Acute Myeloid Leukemia:Big Ten Cancer Research Consortium BTCRC-AML17-113
ClinicalTrials.gov study NCT04070768. IPD Sharing: NO. Countries: 1. Publications: 0.
Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00630565. IPD Sharing: Not stated. Countries: 1. Publications: 0.
S0106A, Biomarkers in Samples From Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Cytarabine-Based Chemotherapy
ClinicalTrials.gov study NCT01360125. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Gemcitabine and Mitoxantrone in Treating Patients With Relapsed Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00268242. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Patients Receiving Induction With Liposomal Daunorubicin and Cytarabine (CPX-351) for Acute Myeloid Leukemia
ClinicalTrials.gov study NCT03988205. IPD Sharing: NO. Countries: 1. Publications: 0.
Entospletinib Monotherapy and in Combination With Chemotherapy in Adults With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT02343939. IPD Sharing: NO. Countries: 3. Publications: 0.
Combination Chemotherapy, Interleukin-2, and Peripheral Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00004128. IPD Sharing: Not stated. Countries: 0. Publications: 4.
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT00372619. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Trial to Find and Investigate a Safe Dose of BI 836858 in Combination With Decitabine for Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT02632721. IPD Sharing: NO. Countries: 4. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.